{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2007/schedule-7/paragraph-9",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2007/schedule-7/paragraph-9.json",
  "legislation": "uksi/2007/2539",
  "legislation_title": "The Veterinary Medicines Regulations 2007",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2007",
  "path": "schedule/7/paragraph/9",
  "kind": "paragraph",
  "number": "9",
  "heading": "Application for a marketing authorisation for an immunological product",
  "text": "(1) The fee for a national application for a marketing authorisation relating to an immunological product, a decentralised application where the United Kingdom is the concerned member State or the mutual recognition of a product authorised in another member State is in accordance with the following table.\nFees for specified immunological applications\nMenu\nNational application for a marketing authorisation(£)\nDecentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£)\nBase fee:\n11,600\n5,700\nThe following fees are in addition to the base fee.\nAdditional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom, and for each new combination of active ingredients:\n7,290\n2,450\nAdditional fee for each adjuvant or preservative not previously included in a veterinary medicinal product authorised in the United Kingdom and for each new combination of adjuvants or preservatives:\n1,330\n660\nMore than one antigenic component—fee for each additional component:\n1,330\n400\nMore than one species—fee for each additional species:\n5,300\n1,590\nMore than one route of administration—fee for each additional route of administration:\n5,300\n1,590\nSimultaneous application—feefor each additional product in the application:\n2,850\n1,660\n(2) The fee for an application for a marketing authorisation for an immunological product that is identical to a product already authorised in the United Kingdom but with a lesser number of antigens and which only contains antigens contained in the product already authorised is £10,270 (United Kingdom only) or £5,300 (decentralised application where the United Kingdom is the concerned member State).",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2007/2539/schedule/7/paragraph/9",
    "retrieved_at": "2026-10-29T03:44:29.692897+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}